查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1566756

免疫檢測市場：按產品、技術、檢體和最終用戶分類：2024-2033 年全球機會分析和產業預測

Immunoassay Market By Product, By Technology By Specimen By End user : Global Opportunity Analysis and Industry Forecast, 2024-2033
出版日期: | 出版商: Allied Market Research | 英文 216 Pages | 商品交期: 2-3個工作天內

價格
簡介目錄

免疫檢測市場

2023年免疫檢測市值為350億美元，預計2024年至2033年複合年成長率為5.8%，到2033年達到616億美元。

免疫檢測是一種生物分析方法，可檢測和定量樣本中蛋白質和抗原的存在。免疫檢測的基本原理依賴抗體與目標分子的相互作用，產生可量化的訊號，例如螢光或顏色變化。此方法可應用於藥物研究、醫學診斷和環境監測。該方法的高特異性和敏感性對於監測藥物水平、診斷疾病、篩檢傳染源和檢測生物標記至關重要。

感染疾病和慢性病的增加是免疫檢測市場的關鍵促進因素。此外，對製藥和生物技術基礎設施的快速投資正在導致基礎設施擴張，推動對臨床試驗、生物標記分析和藥物發現等多種用途的免疫檢測組件的需求。免疫檢測市場的趨勢不斷發展，提高了測試的敏感度和特異性。機器人技術和自動化的整合在市場上越來越受歡迎，因為它有助於提高生產力並減少測試實驗室的人為錯誤。

然而，採購可靠的設備和真實的樣品對於取得良好的結果至關重要。由於行業中零售商稀缺，此類可靠組件的可用性是一項挑戰，限制了免疫檢測市場的開拓。同時，免疫檢測系統製造商也正在努力推出創新產品，為市場開拓創造了機會。預計下一代免疫檢測系統將利用微射流和奈米技術的優勢來提供即時、準確的結果。

按部門審查

免疫檢測市場分為產品、技術、檢體、最終用戶和地區。依產品分類，市場分為試劑/試劑套件和分析儀器。依技術分為ELISA、化學冷光免疫檢測、免疫螢光法、快速診斷法、ELISpot、 西方印漬術等。依檢體，可分為感染疾病、內分泌學、腫瘤學、骨礦物質疾病、循環系統、血液篩檢、自體免疫疾病、過敏診斷、毒理學、新生兒篩檢等。最終使用者分為醫院/診所、臨床實驗室、製藥/生技公司、血庫、研究/學術實驗室和居家醫療環境。從區域來看，分析包括北美、歐洲、亞太地區和拉丁美洲/中東/非洲。

主要發現

依技術分類，ELISA 細分市場 2023 年收益最高。

以檢體來看，血液篩檢板塊於2023年成為第一大股東。

按最終用戶分類，醫院和診所細分市場將在 2023 年獲得較高的市場佔有率。

按地區分類，北美地區 2023 年收益最高。

該報告可以客製化（需要單獨的費用和時間表）。

  • 監管指引
  • 根據客戶興趣加入公司簡介
  • 按國家或地區進行的附加分析 – 市場規模和預測
  • 擴大公司簡介列表
  • 歷史市場資料

目錄

第1章簡介

第 2 章執行摘要

第3章 市場狀況

  • 市場定義和範圍
  • 主要發現
    • 關鍵投資機會
    • 關鍵成功策略
  • 波特五力分析
  • 市場動態
    • 促進因素
    • 抑制因素
    • 機會

第4章免疫檢測市場：依產品

  • 市場概況
  • 試劑和套件
  • 分析儀

第5章免疫檢測市場：依技術分類

  • 市場概況
  • 酵素連結免疫吸附法
  • 化學冷光免疫檢測
  • 螢光免疫分析
  • 快速診斷
  • 酵素連結免疫斑點法
  • 西方印漬術
  • 其他

第 6 章免疫檢測：依市場檢體

  • 市場概況
  • 感染疾病
  • 內分泌學
  • 腫瘤學
  • 骨骼/礦物質疾病
  • 心臟病學
  • 驗血
  • 自體免疫疾病
  • 過敏診斷
  • 毒理學
  • 新生兒篩檢
  • 其他

第7章免疫檢測市場：依最終用戶分類

  • 市場概況
  • 醫院/診所
  • 臨床研究所
  • 製藥和生物技術公司
  • 血庫
  • 研究與學術機構
  • 居家醫療

第8章免疫檢測市場：按地區

  • 市場概況
  • 北美洲
    • 主要市場趨勢和機遇
    • 美國免疫檢測市場
    • 加拿大免疫檢測市場
    • 墨西哥免疫檢測市場
  • 歐洲
    • 主要市場趨勢和機遇
    • 法國免疫檢測市場
    • 德國免疫檢測市場
    • 義大利免疫檢測市場
    • 西班牙免疫檢測市場
    • 英國免疫檢測市場
    • 其他歐洲免疫檢測市場
  • 亞太地區
    • 主要市場趨勢和機遇
    • 中國免疫檢測市場
    • 日本免疫檢測市場
    • 印度免疫檢測市場
    • 韓國免疫檢測市場
    • 澳洲免疫檢測市場
    • 其他亞太免疫檢測市場
  • 拉丁美洲/中東/非洲
    • 主要市場趨勢和機遇
    • 巴西免疫檢測市場
    • 南非免疫檢測市場
    • 沙烏地阿拉伯免疫檢測市場
    • 其他拉丁美洲/中東/非洲免疫檢測市場

第9章 競爭格局

  • 介紹
  • 關鍵成功策略
  • 10家主要企業產品圖譜
  • 有競爭力的儀表板
  • 競爭熱圖
  • 主要企業定位（2023年）

第10章 公司簡介

  • F. Hoffmann-La Roche Ltd.
  • Danaher Corporation
  • Abbott Laboratories
  • Siemens Healthineers
  • DiaSorin SpA
  • Sysmex Corporation
  • BioMerieux SA
  • Ortho Clinical Diagnostics
  • Thermo Fisher Scientific, Inc.
  • Becton, Dickinson And Company
  • Merck KGaA
簡介目錄
Product Code: A00792

Immunoassay Market

The immunoassay market was valued at $35.0 billion in 2023 and is projected to reach $61.6 billion by 2033, growing at a CAGR of 5.8% from 2024 to 2033.

Immunoassay is a bioanalytical method that detects and quantifies the presence of proteins or antigens in a sample. The basic principle of immunoassay relies on the interaction between an antibody and a target molecule, which results in the generation of a quantifiable signal, such as fluorescence or color change. The method finds applications in pharmaceutical research, medical diagnostics, and environmental monitoring. The high specificity & sensitivity of the method is pivotal in monitoring drug levels, diagnosing diseases, screening for infectious agents, and detecting biomarkers.

Rise in the prevalence of infectious and chronic diseases is a significant driver of the immunoassay market. In addition, surge in investments in the pharmaceutical & biotechnology infrastructure has led to the expansion in infrastructure, thereby boosting the demand for immunoassay components for diverse purposes such as clinical trials, biomarker analysis, and drug discovery. Trends in the immunoassay market evolve constantly, enhancing the sensitivity and specificity of the tests. The integration of robotics and automation is acquiring traction in the market as it is enhancing productivity and helping to reduce human error in the laboratories.

However, procuring reliable instruments and authentic samples to critical for obtaining successful results. The acquisition of such trustworthy components is a challenging task owing to less retailers in the industry, thereby restraining the development of the immunoassay market. On the contrary, manufacturers of immunoassay systems strive to introduce innovative products, thereby presenting lucrative opportunities for market development. Next generation of immunoassay systems is projected to leverage the benefits of microfluidics and nanotechnology for achieving instant & accurate results.

Segment Review

The immunoassay market is segmented into product, technology, specimen, end user, and region. On the basis of product, the market is bifurcated into reagents & kits and analyzers. As per technology, it is classified into ELISA, chemiluminescence immunoassay, immunofluorescence assay, rapid test, ELISpot, western blotting, and others. According to specimen, it is categorized into infectious diseases, endocrinology, oncology, bone & mineral disorders, cardiology, blood screening, autoimmune disorders, allergy diagnostics, toxicology, newborn screening, and others. By end user, it is divided into hospitals & clinics, clinical laboratories, pharmaceutical & biotechnology companies, blood banks, research & academic laboratories, and home care settings. Region wise, it is analyzed across North America, Europe, Asia-Pacific, and LAMEA.

Key Findings

As per technology, the ELISA segment generated the highest revenue in 2023.

According to specimen, the blood screening segment was the highest shareholder in 2023.

By end user, the hospitals & clinics segment acquired high market stakes in 2023.

Region wise, North America was the highest revenue generator in 2023.

Competition Analysis

The major players operating in the global immunoassay market include F. Hoffmann-La Roche Ltd., Danaher Corporation, Abbott Laboratories, Siemens Healthineers, DiaSorin S.p.A., Sysmex Corporation, BioMerieux SA, Ortho Clinical Diagnostics, Thermo Fisher Scientific, Inc., Becton, Dickinson and Company, and Merck kGaA. These players have adopted various key developmental strategies such as business expansion, new product launches, and partnerships to strengthen their foothold in the market.

Additional benefits you will get with this purchase are:

  • Quarterly Update and* (only available with a corporate license, on listed price)
  • 5 additional Company Profile of client Choice pre- or Post-purchase, as a free update.
  • Free Upcoming Version on the Purchase of Five and Enterprise User License.
  • 16 analyst hours of support* (post-purchase, if you find additional data requirements upon review of the report, you may receive support amounting to 16 analyst hours to solve questions, and post-sale queries)
  • 15% Free Customization* (in case the scope or segment of the report does not match your requirements, 15% is equivalent to 3 working days of free work, applicable once)
  • Free data Pack on the Five and Enterprise User License. (Excel version of the report)
  • Free Updated report if the report is 6-12 months old or older.
  • 24-hour priority response*
  • Free Industry updates and white papers.

Possible Customization with this report (with additional cost and timeline, please talk to the sales executive to know more)

  • Regulatory Guidelines
  • Additional company profiles with specific to client's interest
  • Additional country or region analysis- market size and forecast
  • Expanded list for Company Profiles
  • Historic market data

Key Market Segments

By Product

  • Reagents and Kits
  • Analyzers

By Technology

  • ELISA
  • Chemiluminescence Immunoassay
  • Immunofluorescence assay
  • Rapid Test
  • ELISpot
  • Western Blotting
  • Others

By Specimen

  • Infectious Diseases
  • Endocrinology
  • Oncology
  • Bone and Mineral Disorders
  • Cardiology
  • Blood Screening
  • Autoimmune Disorders
  • Allergy Diagnostics
  • Toxicology
  • Newborn Screening
  • Others

By End User

  • Hospitals and Clinics
  • Clinical Laboratories
  • Pharmaceutical and Biotechnology Companies
  • Blood Banks
  • Research and Academic Laboratories
  • Home Care Settings

By Region

  • North America
    • U.S.
    • Canada
    • Mexico
  • Europe
    • France
    • Germany
    • Italy
    • Spain
    • UK
    • Rest of Europe
  • Asia-Pacific
    • China
    • Japan
    • India
    • South Korea
    • Australia
    • Rest of Asia-Pacific
  • LAMEA
    • Brazil
    • South Africa
    • Saudi Arabia
    • Rest of LAMEA

Key Market Players:

    • F. Hoffmann-La Roche Ltd.
    • Danaher Corporation
    • Abbott Laboratories
    • Siemens Healthineers
    • DiaSorin S.p.A.
    • Sysmex Corporation
    • BioMerieux SA
    • Ortho Clinical Diagnostics
    • Thermo Fisher Scientific, Inc.
    • Becton, Dickinson and Company
    • Merck kGaA

TABLE OF CONTENTS

CHAPTER 1: INTRODUCTION

  • 1.1. Report Description
  • 1.2. Key Market Segments
  • 1.3. Key Benefits
  • 1.4. Research Methodology
    • 1.4.1. Primary Research
    • 1.4.2. Secondary Research
    • 1.4.3. Analyst Tools and Models

CHAPTER 2: EXECUTIVE SUMMARY

  • 2.1. CXO Perspective

CHAPTER 3: MARKET LANDSCAPE

  • 3.1. Market Definition and Scope
  • 3.2. Key Findings
    • 3.2.1. Top Investment Pockets
    • 3.2.2. Top Winning Strategies
  • 3.3. Porter's Five Forces Analysis
    • 3.3.1. Bargaining Power of Suppliers
    • 3.3.2. Threat of New Entrants
    • 3.3.3. Threat of Substitutes
    • 3.3.4. Competitive Rivalry
    • 3.3.5. Bargaining Power among Buyers
  • 3.4. Market Dynamics
    • 3.4.1. Drivers
    • 3.4.2. Restraints
    • 3.4.3. Opportunities

CHAPTER 4: IMMUNOASSAY MARKET, BY PRODUCT

  • 4.1. Market Overview
    • 4.1.1 Market Size and Forecast, By Product
  • 4.2. Reagents And Kits
    • 4.2.1. Key Market Trends, Growth Factors and Opportunities
    • 4.2.2. Market Size and Forecast, By Region
    • 4.2.3. Market Share Analysis, By Country
  • 4.3. Analyzers
    • 4.3.1. Key Market Trends, Growth Factors and Opportunities
    • 4.3.2. Market Size and Forecast, By Region
    • 4.3.3. Market Share Analysis, By Country

CHAPTER 5: IMMUNOASSAY MARKET, BY TECHNOLOGY

  • 5.1. Market Overview
    • 5.1.1 Market Size and Forecast, By Technology
  • 5.2. ELISA
    • 5.2.1. Key Market Trends, Growth Factors and Opportunities
    • 5.2.2. Market Size and Forecast, By Region
    • 5.2.3. Market Share Analysis, By Country
  • 5.3. Chemiluminescence Immunoassay
    • 5.3.1. Key Market Trends, Growth Factors and Opportunities
    • 5.3.2. Market Size and Forecast, By Region
    • 5.3.3. Market Share Analysis, By Country
  • 5.4. Immunofluorescence Assay
    • 5.4.1. Key Market Trends, Growth Factors and Opportunities
    • 5.4.2. Market Size and Forecast, By Region
    • 5.4.3. Market Share Analysis, By Country
  • 5.5. Rapid Test
    • 5.5.1. Key Market Trends, Growth Factors and Opportunities
    • 5.5.2. Market Size and Forecast, By Region
    • 5.5.3. Market Share Analysis, By Country
  • 5.6. ELISpot
    • 5.6.1. Key Market Trends, Growth Factors and Opportunities
    • 5.6.2. Market Size and Forecast, By Region
    • 5.6.3. Market Share Analysis, By Country
  • 5.7. Western Blotting
    • 5.7.1. Key Market Trends, Growth Factors and Opportunities
    • 5.7.2. Market Size and Forecast, By Region
    • 5.7.3. Market Share Analysis, By Country
  • 5.8. Others
    • 5.8.1. Key Market Trends, Growth Factors and Opportunities
    • 5.8.2. Market Size and Forecast, By Region
    • 5.8.3. Market Share Analysis, By Country

CHAPTER 6: IMMUNOASSAY MARKET, BY SPECIMEN

  • 6.1. Market Overview
    • 6.1.1 Market Size and Forecast, By Specimen
  • 6.2. Infectious Diseases
    • 6.2.1. Key Market Trends, Growth Factors and Opportunities
    • 6.2.2. Market Size and Forecast, By Region
    • 6.2.3. Market Share Analysis, By Country
  • 6.3. Endocrinology
    • 6.3.1. Key Market Trends, Growth Factors and Opportunities
    • 6.3.2. Market Size and Forecast, By Region
    • 6.3.3. Market Share Analysis, By Country
  • 6.4. Oncology
    • 6.4.1. Key Market Trends, Growth Factors and Opportunities
    • 6.4.2. Market Size and Forecast, By Region
    • 6.4.3. Market Share Analysis, By Country
  • 6.5. Bone And Mineral Disorders
    • 6.5.1. Key Market Trends, Growth Factors and Opportunities
    • 6.5.2. Market Size and Forecast, By Region
    • 6.5.3. Market Share Analysis, By Country
  • 6.6. Cardiology
    • 6.6.1. Key Market Trends, Growth Factors and Opportunities
    • 6.6.2. Market Size and Forecast, By Region
    • 6.6.3. Market Share Analysis, By Country
  • 6.7. Blood Screening
    • 6.7.1. Key Market Trends, Growth Factors and Opportunities
    • 6.7.2. Market Size and Forecast, By Region
    • 6.7.3. Market Share Analysis, By Country
  • 6.8. Autoimmune Disorders
    • 6.8.1. Key Market Trends, Growth Factors and Opportunities
    • 6.8.2. Market Size and Forecast, By Region
    • 6.8.3. Market Share Analysis, By Country
  • 6.9. Allergy Diagnostics
    • 6.9.1. Key Market Trends, Growth Factors and Opportunities
    • 6.9.2. Market Size and Forecast, By Region
    • 6.9.3. Market Share Analysis, By Country
  • 6.10. Toxicology
    • 6.10.1. Key Market Trends, Growth Factors and Opportunities
    • 6.10.2. Market Size and Forecast, By Region
    • 6.10.3. Market Share Analysis, By Country
  • 6.11. Newborn Screening
    • 6.11.1. Key Market Trends, Growth Factors and Opportunities
    • 6.11.2. Market Size and Forecast, By Region
    • 6.11.3. Market Share Analysis, By Country
  • 6.12. Others
    • 6.12.1. Key Market Trends, Growth Factors and Opportunities
    • 6.12.2. Market Size and Forecast, By Region
    • 6.12.3. Market Share Analysis, By Country

CHAPTER 7: IMMUNOASSAY MARKET, BY END USER

  • 7.1. Market Overview
    • 7.1.1 Market Size and Forecast, By End User
  • 7.2. Hospitals And Clinics
    • 7.2.1. Key Market Trends, Growth Factors and Opportunities
    • 7.2.2. Market Size and Forecast, By Region
    • 7.2.3. Market Share Analysis, By Country
  • 7.3. Clinical Laboratories
    • 7.3.1. Key Market Trends, Growth Factors and Opportunities
    • 7.3.2. Market Size and Forecast, By Region
    • 7.3.3. Market Share Analysis, By Country
  • 7.4. Pharmaceutical And Biotechnology Companies
    • 7.4.1. Key Market Trends, Growth Factors and Opportunities
    • 7.4.2. Market Size and Forecast, By Region
    • 7.4.3. Market Share Analysis, By Country
  • 7.5. Blood Banks
    • 7.5.1. Key Market Trends, Growth Factors and Opportunities
    • 7.5.2. Market Size and Forecast, By Region
    • 7.5.3. Market Share Analysis, By Country
  • 7.6. Research And Academic Laboratories
    • 7.6.1. Key Market Trends, Growth Factors and Opportunities
    • 7.6.2. Market Size and Forecast, By Region
    • 7.6.3. Market Share Analysis, By Country
  • 7.7. Home Care Settings
    • 7.7.1. Key Market Trends, Growth Factors and Opportunities
    • 7.7.2. Market Size and Forecast, By Region
    • 7.7.3. Market Share Analysis, By Country

CHAPTER 8: IMMUNOASSAY MARKET, BY REGION

  • 8.1. Market Overview
    • 8.1.1 Market Size and Forecast, By Region
  • 8.2. North America
    • 8.2.1. Key Market Trends and Opportunities
    • 8.2.2. Market Size and Forecast, By Product
    • 8.2.3. Market Size and Forecast, By Technology
    • 8.2.4. Market Size and Forecast, By Specimen
    • 8.2.5. Market Size and Forecast, By End User
    • 8.2.6. Market Size and Forecast, By Country
    • 8.2.7. U.S. Immunoassay Market
      • 8.2.7.1. Market Size and Forecast, By Product
      • 8.2.7.2. Market Size and Forecast, By Technology
      • 8.2.7.3. Market Size and Forecast, By Specimen
      • 8.2.7.4. Market Size and Forecast, By End User
    • 8.2.8. Canada Immunoassay Market
      • 8.2.8.1. Market Size and Forecast, By Product
      • 8.2.8.2. Market Size and Forecast, By Technology
      • 8.2.8.3. Market Size and Forecast, By Specimen
      • 8.2.8.4. Market Size and Forecast, By End User
    • 8.2.9. Mexico Immunoassay Market
      • 8.2.9.1. Market Size and Forecast, By Product
      • 8.2.9.2. Market Size and Forecast, By Technology
      • 8.2.9.3. Market Size and Forecast, By Specimen
      • 8.2.9.4. Market Size and Forecast, By End User
  • 8.3. Europe
    • 8.3.1. Key Market Trends and Opportunities
    • 8.3.2. Market Size and Forecast, By Product
    • 8.3.3. Market Size and Forecast, By Technology
    • 8.3.4. Market Size and Forecast, By Specimen
    • 8.3.5. Market Size and Forecast, By End User
    • 8.3.6. Market Size and Forecast, By Country
    • 8.3.7. France Immunoassay Market
      • 8.3.7.1. Market Size and Forecast, By Product
      • 8.3.7.2. Market Size and Forecast, By Technology
      • 8.3.7.3. Market Size and Forecast, By Specimen
      • 8.3.7.4. Market Size and Forecast, By End User
    • 8.3.8. Germany Immunoassay Market
      • 8.3.8.1. Market Size and Forecast, By Product
      • 8.3.8.2. Market Size and Forecast, By Technology
      • 8.3.8.3. Market Size and Forecast, By Specimen
      • 8.3.8.4. Market Size and Forecast, By End User
    • 8.3.9. Italy Immunoassay Market
      • 8.3.9.1. Market Size and Forecast, By Product
      • 8.3.9.2. Market Size and Forecast, By Technology
      • 8.3.9.3. Market Size and Forecast, By Specimen
      • 8.3.9.4. Market Size and Forecast, By End User
    • 8.3.10. Spain Immunoassay Market
      • 8.3.10.1. Market Size and Forecast, By Product
      • 8.3.10.2. Market Size and Forecast, By Technology
      • 8.3.10.3. Market Size and Forecast, By Specimen
      • 8.3.10.4. Market Size and Forecast, By End User
    • 8.3.11. UK Immunoassay Market
      • 8.3.11.1. Market Size and Forecast, By Product
      • 8.3.11.2. Market Size and Forecast, By Technology
      • 8.3.11.3. Market Size and Forecast, By Specimen
      • 8.3.11.4. Market Size and Forecast, By End User
    • 8.3.12. Rest of Europe Immunoassay Market
      • 8.3.12.1. Market Size and Forecast, By Product
      • 8.3.12.2. Market Size and Forecast, By Technology
      • 8.3.12.3. Market Size and Forecast, By Specimen
      • 8.3.12.4. Market Size and Forecast, By End User
  • 8.4. Asia-Pacific
    • 8.4.1. Key Market Trends and Opportunities
    • 8.4.2. Market Size and Forecast, By Product
    • 8.4.3. Market Size and Forecast, By Technology
    • 8.4.4. Market Size and Forecast, By Specimen
    • 8.4.5. Market Size and Forecast, By End User
    • 8.4.6. Market Size and Forecast, By Country
    • 8.4.7. China Immunoassay Market
      • 8.4.7.1. Market Size and Forecast, By Product
      • 8.4.7.2. Market Size and Forecast, By Technology
      • 8.4.7.3. Market Size and Forecast, By Specimen
      • 8.4.7.4. Market Size and Forecast, By End User
    • 8.4.8. Japan Immunoassay Market
      • 8.4.8.1. Market Size and Forecast, By Product
      • 8.4.8.2. Market Size and Forecast, By Technology
      • 8.4.8.3. Market Size and Forecast, By Specimen
      • 8.4.8.4. Market Size and Forecast, By End User
    • 8.4.9. India Immunoassay Market
      • 8.4.9.1. Market Size and Forecast, By Product
      • 8.4.9.2. Market Size and Forecast, By Technology
      • 8.4.9.3. Market Size and Forecast, By Specimen
      • 8.4.9.4. Market Size and Forecast, By End User
    • 8.4.10. South Korea Immunoassay Market
      • 8.4.10.1. Market Size and Forecast, By Product
      • 8.4.10.2. Market Size and Forecast, By Technology
      • 8.4.10.3. Market Size and Forecast, By Specimen
      • 8.4.10.4. Market Size and Forecast, By End User
    • 8.4.11. Australia Immunoassay Market
      • 8.4.11.1. Market Size and Forecast, By Product
      • 8.4.11.2. Market Size and Forecast, By Technology
      • 8.4.11.3. Market Size and Forecast, By Specimen
      • 8.4.11.4. Market Size and Forecast, By End User
    • 8.4.12. Rest of Asia-Pacific Immunoassay Market
      • 8.4.12.1. Market Size and Forecast, By Product
      • 8.4.12.2. Market Size and Forecast, By Technology
      • 8.4.12.3. Market Size and Forecast, By Specimen
      • 8.4.12.4. Market Size and Forecast, By End User
  • 8.5. LAMEA
    • 8.5.1. Key Market Trends and Opportunities
    • 8.5.2. Market Size and Forecast, By Product
    • 8.5.3. Market Size and Forecast, By Technology
    • 8.5.4. Market Size and Forecast, By Specimen
    • 8.5.5. Market Size and Forecast, By End User
    • 8.5.6. Market Size and Forecast, By Country
    • 8.5.7. Brazil Immunoassay Market
      • 8.5.7.1. Market Size and Forecast, By Product
      • 8.5.7.2. Market Size and Forecast, By Technology
      • 8.5.7.3. Market Size and Forecast, By Specimen
      • 8.5.7.4. Market Size and Forecast, By End User
    • 8.5.8. South Africa Immunoassay Market
      • 8.5.8.1. Market Size and Forecast, By Product
      • 8.5.8.2. Market Size and Forecast, By Technology
      • 8.5.8.3. Market Size and Forecast, By Specimen
      • 8.5.8.4. Market Size and Forecast, By End User
    • 8.5.9. Saudi Arabia Immunoassay Market
      • 8.5.9.1. Market Size and Forecast, By Product
      • 8.5.9.2. Market Size and Forecast, By Technology
      • 8.5.9.3. Market Size and Forecast, By Specimen
      • 8.5.9.4. Market Size and Forecast, By End User
    • 8.5.10. Rest of LAMEA Immunoassay Market
      • 8.5.10.1. Market Size and Forecast, By Product
      • 8.5.10.2. Market Size and Forecast, By Technology
      • 8.5.10.3. Market Size and Forecast, By Specimen
      • 8.5.10.4. Market Size and Forecast, By End User

CHAPTER 9: COMPETITIVE LANDSCAPE

  • 9.1. Introduction
  • 9.2. Top Winning Strategies
  • 9.3. Product Mapping of Top 10 Player
  • 9.4. Competitive Dashboard
  • 9.5. Competitive Heatmap
  • 9.6. Top Player Positioning, 2023

CHAPTER 10: COMPANY PROFILES

  • 10.1. F. Hoffmann-La Roche Ltd.
    • 10.1.1. Company Overview
    • 10.1.2. Key Executives
    • 10.1.3. Company Snapshot
    • 10.1.4. Operating Business Segments
    • 10.1.5. Product Portfolio
    • 10.1.6. Business Performance
    • 10.1.7. Key Strategic Moves and Developments
  • 10.2. Danaher Corporation
    • 10.2.1. Company Overview
    • 10.2.2. Key Executives
    • 10.2.3. Company Snapshot
    • 10.2.4. Operating Business Segments
    • 10.2.5. Product Portfolio
    • 10.2.6. Business Performance
    • 10.2.7. Key Strategic Moves and Developments
  • 10.3. Abbott Laboratories
    • 10.3.1. Company Overview
    • 10.3.2. Key Executives
    • 10.3.3. Company Snapshot
    • 10.3.4. Operating Business Segments
    • 10.3.5. Product Portfolio
    • 10.3.6. Business Performance
    • 10.3.7. Key Strategic Moves and Developments
  • 10.4. Siemens Healthineers
    • 10.4.1. Company Overview
    • 10.4.2. Key Executives
    • 10.4.3. Company Snapshot
    • 10.4.4. Operating Business Segments
    • 10.4.5. Product Portfolio
    • 10.4.6. Business Performance
    • 10.4.7. Key Strategic Moves and Developments
  • 10.5. DiaSorin S.p.A.
    • 10.5.1. Company Overview
    • 10.5.2. Key Executives
    • 10.5.3. Company Snapshot
    • 10.5.4. Operating Business Segments
    • 10.5.5. Product Portfolio
    • 10.5.6. Business Performance
    • 10.5.7. Key Strategic Moves and Developments
  • 10.6. Sysmex Corporation
    • 10.6.1. Company Overview
    • 10.6.2. Key Executives
    • 10.6.3. Company Snapshot
    • 10.6.4. Operating Business Segments
    • 10.6.5. Product Portfolio
    • 10.6.6. Business Performance
    • 10.6.7. Key Strategic Moves and Developments
  • 10.7. BioMerieux SA
    • 10.7.1. Company Overview
    • 10.7.2. Key Executives
    • 10.7.3. Company Snapshot
    • 10.7.4. Operating Business Segments
    • 10.7.5. Product Portfolio
    • 10.7.6. Business Performance
    • 10.7.7. Key Strategic Moves and Developments
  • 10.8. Ortho Clinical Diagnostics
    • 10.8.1. Company Overview
    • 10.8.2. Key Executives
    • 10.8.3. Company Snapshot
    • 10.8.4. Operating Business Segments
    • 10.8.5. Product Portfolio
    • 10.8.6. Business Performance
    • 10.8.7. Key Strategic Moves and Developments
  • 10.9. Thermo Fisher Scientific, Inc.
    • 10.9.1. Company Overview
    • 10.9.2. Key Executives
    • 10.9.3. Company Snapshot
    • 10.9.4. Operating Business Segments
    • 10.9.5. Product Portfolio
    • 10.9.6. Business Performance
    • 10.9.7. Key Strategic Moves and Developments
  • 10.10. Becton, Dickinson And Company
    • 10.10.1. Company Overview
    • 10.10.2. Key Executives
    • 10.10.3. Company Snapshot
    • 10.10.4. Operating Business Segments
    • 10.10.5. Product Portfolio
    • 10.10.6. Business Performance
    • 10.10.7. Key Strategic Moves and Developments
  • 10.11. Merck KGaA
    • 10.11.1. Company Overview
    • 10.11.2. Key Executives
    • 10.11.3. Company Snapshot
    • 10.11.4. Operating Business Segments
    • 10.11.5. Product Portfolio
    • 10.11.6. Business Performance
    • 10.11.7. Key Strategic Moves and Developments